• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

影响免疫细胞功能的肿瘤微环境特征:缺氧、氧化应激、代谢改变

Characteristics of the Tumor Microenvironment That Influence Immune Cell Functions: Hypoxia, Oxidative Stress, Metabolic Alterations.

作者信息

Augustin Ryan C, Delgoffe Greg M, Najjar Yana G

机构信息

Department of Medicine, University of Pittsburgh, Pittsburgh, PA 15260, USA.

Department of Immunology, University of Pittsburgh, Pittsburgh, PA 15260, USA.

出版信息

Cancers (Basel). 2020 Dec 17;12(12):3802. doi: 10.3390/cancers12123802.

DOI:10.3390/cancers12123802
PMID:33348579
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7765870/
Abstract

Immunotherapy (IMT) is now a core component of cancer treatment, however, many patients do not respond to these novel therapies. Investigating the resistance mechanisms behind this differential response is now a critical area of research. Immune-based therapies, particularly immune checkpoint inhibitors (ICI), rely on a robust infiltration of T-cells into the tumor microenvironment (TME) for an effective response. While early efforts relied on quantifying tumor infiltrating lymphocytes (TIL) in the TME, characterizing the functional quality and degree of TIL exhaustion correlates more strongly with ICI response. Even with sufficient TME infiltration, immune cells face a harsh metabolic environment that can significantly impair effector function. These tumor-mediated metabolic perturbations include hypoxia, oxidative stress, and metabolites of cellular energetics. Primarily through HIF-1-dependent processes, hypoxia invokes an immunosuppressive phenotype via altered molecular markers, immune cell trafficking, and angiogenesis. Additionally, oxidative stress can promote lipid peroxidation, ER stress, and Treg dysfunction, all associated with immune dysregulation. Finally, the metabolic byproducts of lipids, amino acids, glucose, and cellular energetics are associated with immunosuppression and ICI resistance. This review will explore these biochemical pathways linked to immune cell dysfunction in the TME and highlight potential adjunctive therapies to be used alongside current IMT.

摘要

免疫疗法(IMT)如今是癌症治疗的核心组成部分,然而,许多患者对这些新型疗法并无反应。探究这种差异反应背后的耐药机制是当前一个关键的研究领域。基于免疫的疗法,尤其是免疫检查点抑制剂(ICI),依赖T细胞大量浸润到肿瘤微环境(TME)中才能产生有效反应。早期研究致力于量化TME中的肿瘤浸润淋巴细胞(TIL),而TIL耗竭的功能质量和程度与ICI反应的相关性更强。即使TME中有足够的浸润,免疫细胞仍面临恶劣的代谢环境,这会显著损害效应功能。这些肿瘤介导的代谢紊乱包括缺氧、氧化应激和细胞能量代谢产物。缺氧主要通过依赖缺氧诱导因子-1(HIF-1)的过程,通过改变分子标志物、免疫细胞运输和血管生成来引发免疫抑制表型。此外,氧化应激可促进脂质过氧化、内质网应激和调节性T细胞(Treg)功能障碍,所有这些都与免疫失调有关。最后,脂质、氨基酸、葡萄糖和细胞能量代谢的副产物与免疫抑制和ICI耐药相关。本综述将探讨这些与TME中免疫细胞功能障碍相关的生化途径,并重点介绍可与当前IMT联合使用的潜在辅助疗法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc7a/7765870/0335cbcaa349/cancers-12-03802-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc7a/7765870/0335cbcaa349/cancers-12-03802-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc7a/7765870/0335cbcaa349/cancers-12-03802-g001.jpg

相似文献

1
Characteristics of the Tumor Microenvironment That Influence Immune Cell Functions: Hypoxia, Oxidative Stress, Metabolic Alterations.影响免疫细胞功能的肿瘤微环境特征:缺氧、氧化应激、代谢改变
Cancers (Basel). 2020 Dec 17;12(12):3802. doi: 10.3390/cancers12123802.
2
Metabolic advantages of regulatory T cells dictated by cancer cells.癌细胞决定的调节性T细胞的代谢优势。
Int Immunol. 2024 Feb 14;36(2):75-86. doi: 10.1093/intimm/dxad035.
3
Altered cancer metabolism in mechanisms of immunotherapy resistance.免疫治疗耐药机制中的肿瘤代谢改变。
Pharmacol Ther. 2019 Mar;195:162-171. doi: 10.1016/j.pharmthera.2018.11.004. Epub 2018 Nov 12.
4
Immunometabolism in the Bladder Cancer Microenvironment.膀胱癌微环境中的免疫代谢。
Endocr Metab Immune Disord Drug Targets. 2022;22(12):1201-1216. doi: 10.2174/1871530322666220104103905.
5
Balancing cancer immunotherapy and immune-related adverse events: The emerging role of regulatory T cells.平衡癌症免疫疗法和免疫相关不良事件:调节性 T 细胞的新作用。
J Autoimmun. 2019 Nov;104:102310. doi: 10.1016/j.jaut.2019.102310. Epub 2019 Aug 15.
6
[Immunosuppressive Environment in Tumors].[肿瘤中的免疫抑制环境]
Gan To Kagaku Ryoho. 2018 Feb;45(2):222-226.
7
Hypoxia as a barrier to immunotherapy in pancreatic adenocarcinoma.缺氧作为胰腺腺癌免疫治疗的障碍。
Clin Transl Med. 2019 Apr 1;8(1):10. doi: 10.1186/s40169-019-0226-9.
8
Immunity, Hypoxia, and Metabolism-the Ménage à Trois of Cancer: Implications for Immunotherapy.免疫、缺氧与代谢:癌症的“三人行”——对免疫治疗的启示。
Physiol Rev. 2020 Jan 1;100(1):1-102. doi: 10.1152/physrev.00018.2019. Epub 2019 Aug 15.
9
Sculpting tumor microenvironment with immune system: from immunometabolism to immunoediting.利用免疫系统塑造肿瘤微环境:从免疫代谢到免疫编辑。
Clin Exp Immunol. 2019 Aug;197(2):153-160. doi: 10.1111/cei.13293. Epub 2019 Apr 1.
10
Redox Signaling Modulates Activity of Immune Checkpoint Inhibitors in Cancer Patients.氧化还原信号传导调节癌症患者免疫检查点抑制剂的活性。
Biomedicines. 2023 Apr 29;11(5):1325. doi: 10.3390/biomedicines11051325.

引用本文的文献

1
Mechanisms of T-cell metabolic reprogramming in the microenvironment of acute myeloid leukemia and its therapeutic potential (Review).急性髓系白血病微环境中T细胞代谢重编程的机制及其治疗潜力(综述)
Oncol Lett. 2025 Jul 22;30(4):455. doi: 10.3892/ol.2025.15201. eCollection 2025 Oct.
2
Integrative network pharmacology and multi-omics reveal anisodamine hydrobromide's multi-target mechanisms in sepsis.整合网络药理学和多组学揭示氢溴酸山莨菪碱在脓毒症中的多靶点作用机制。
Sci Rep. 2025 Jul 31;15(1):27996. doi: 10.1038/s41598-025-13187-w.
3
Selection of Stable Reference Genes for Gene Expression Studies in Activated and Non-Activated PBMCs Under Normoxic and Hypoxic Conditions.

本文引用的文献

1
Metabolic crosstalk in the tumor microenvironment regulates antitumor immunosuppression and immunotherapy resisitance.肿瘤微环境中的代谢串扰调节抗肿瘤免疫抑制和免疫治疗抵抗。
Cell Mol Life Sci. 2021 Jan;78(1):173-193. doi: 10.1007/s00018-020-03581-0. Epub 2020 Jul 11.
2
Metabolite sensing and signaling in cancer.癌症中的代谢物感应和信号传递。
J Biol Chem. 2020 Aug 14;295(33):11938-11946. doi: 10.1074/jbc.REV119.007624. Epub 2020 Jul 7.
3
Reactive Oxygen Species and Antitumor Immunity-From Surveillance to Evasion.活性氧与抗肿瘤免疫——从监测到逃逸
在常氧和低氧条件下活化及未活化外周血单个核细胞中用于基因表达研究的稳定内参基因的选择
Int J Mol Sci. 2025 Jul 15;26(14):6790. doi: 10.3390/ijms26146790.
4
Hydrogels as advanced drug delivery platforms for cancer immunotherapy: promising innovations and future outlook.水凝胶作为癌症免疫治疗的先进药物递送平台:有前景的创新与未来展望。
J Nanobiotechnology. 2025 Jul 28;23(1):545. doi: 10.1186/s12951-025-03613-6.
5
Deciphering hypoxia's role in hepatocellular carcinoma prognosis with single-cell approaches.利用单细胞方法解读缺氧在肝细胞癌预后中的作用。
Discov Oncol. 2025 Jul 26;16(1):1411. doi: 10.1007/s12672-025-03201-y.
6
Influence of Hypoxia on Tumor Heterogeneity, DNA Repair, and Cancer Therapy: From Molecular Insights to Therapeutic Strategies.缺氧对肿瘤异质性、DNA修复及癌症治疗的影响:从分子洞察到治疗策略
Cells. 2025 Jul 10;14(14):1057. doi: 10.3390/cells14141057.
7
Multi-omics analysis reveals glutathione metabolism-related immune suppression and constructs a prognostic model in lung adenocarcinoma.多组学分析揭示了与谷胱甘肽代谢相关的免疫抑制作用,并构建了肺腺癌的预后模型。
Front Immunol. 2025 Jul 2;16:1608407. doi: 10.3389/fimmu.2025.1608407. eCollection 2025.
8
HIF-1α-Mediated Disruption of Cellular Junctions: The Impact of Hypoxia on the Tumor Microenvironment and Invasion.缺氧诱导因子-1α介导的细胞连接破坏:缺氧对肿瘤微环境和侵袭的影响
Int J Mol Sci. 2025 May 26;26(11):5101. doi: 10.3390/ijms26115101.
9
Decoding tumor angiogenesis: pathways, mechanisms, and future directions in anti-cancer strategies.解码肿瘤血管生成:抗癌策略中的途径、机制及未来方向
Biomark Res. 2025 Apr 18;13(1):62. doi: 10.1186/s40364-025-00779-x.
10
Hypoxia-associated genes as predictors of outcomes in gastric cancer: a genomic approach.缺氧相关基因作为胃癌预后的预测指标:一种基因组学方法
Front Immunol. 2025 Mar 10;16:1553477. doi: 10.3389/fimmu.2025.1553477. eCollection 2025.
Cancers (Basel). 2020 Jul 1;12(7):1748. doi: 10.3390/cancers12071748.
4
The tumor microenvironment as a metabolic barrier to effector T cells and immunotherapy.肿瘤微环境作为效应 T 细胞和免疫疗法的代谢障碍。
Elife. 2020 May 5;9:e55185. doi: 10.7554/eLife.55185.
5
Scientific Rationale for Combined Immunotherapy with PD-1/PD-L1 Antibodies and VEGF Inhibitors in Advanced Hepatocellular Carcinoma.晚期肝细胞癌中PD-1/PD-L1抗体与VEGF抑制剂联合免疫治疗的科学依据
Cancers (Basel). 2020 Apr 27;12(5):1089. doi: 10.3390/cancers12051089.
6
Resistance of melanoma to immune checkpoint inhibitors is overcome by targeting the sphingosine kinase-1.通过靶向鞘氨醇激酶-1 克服黑色素瘤对免疫检查点抑制剂的耐药性。
Nat Commun. 2020 Jan 23;11(1):437. doi: 10.1038/s41467-019-14218-7.
7
Monocarboxylate transporter 1 blockade with AZD3965 inhibits lipid biosynthesis and increases tumour immune cell infiltration.单羧酸转运蛋白 1 阻断剂 AZD3965 抑制脂质生物合成并增加肿瘤免疫细胞浸润。
Br J Cancer. 2020 Mar;122(6):895-903. doi: 10.1038/s41416-019-0717-x. Epub 2020 Jan 15.
8
Altered Lipid Tumor Environment and Its Potential Effects on NKT Cell Function in Tumor Immunity.脂质肿瘤微环境的改变及其对肿瘤免疫中 NKT 细胞功能的潜在影响。
Front Immunol. 2019 Sep 18;10:2187. doi: 10.3389/fimmu.2019.02187. eCollection 2019.
9
Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma.纳武利尤单抗联合伊匹木单抗治疗晚期黑色素瘤的 5 年生存数据
N Engl J Med. 2019 Oct 17;381(16):1535-1546. doi: 10.1056/NEJMoa1910836. Epub 2019 Sep 28.
10
Improving Cancer Immunotherapy by Targeting the Hypoxic Tumor Microenvironment: New Opportunities and Challenges.通过靶向缺氧肿瘤微环境改善癌症免疫治疗:新的机遇和挑战。
Cells. 2019 Sep 14;8(9):1083. doi: 10.3390/cells8091083.